Work

Initial Results from the Frailty-Stratified, Randomised Controlled Bayesian Adaptive Trial of Bortezomib Versus Lenalidomide in Transplant Ineligible Myeloma (TI-NDMM) - the FRAIL-M Study (AMaRC 19-01; ALLG MM22)

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-209640

Authors: Sueh-Li Lim, John Reynolds, Lucy Pemberton, Tricia Wright, Sophie Hyesuk Lee, Peter Mollee, Anita C Shetty, Helen Weston, Nina Byard, Khoa Le, Zoe K McQuilten, Hang Quach, Andrew Spencer

Institutions: The Alfred Hospital, Alfred Health, Monash University, Dunedin Public Hospital, Latrobe Regional Hospital, Western Health, Princess Alexandra Hospital, Nepean Hospital, Sunshine Coast University Hospital, St Vincent's Hospital Melbourne

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405038872

Cites:

Cited by: 4

Related to: 10